Nathaniel E. David
2018
In 2018, Nathaniel E. David earned a total compensation of $2.9M as President at Unity Biotechnology, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,932 |
|---|---|
| Option Awards | $611,271 |
| Salary | $437,750 |
| Other | $1,639,038 |
| Total | $2,863,991 |
David received $1.6M in other compensation, accounting for 57% of the total pay in 2018.
David also received $175.9K in non-equity incentive plan, $611.3K in option awards and $437.8K in salary.
Rankings
In 2018, Nathaniel E. David's compensation ranked 4,064th out of 14,244 executives tracked by ExecPay. In other words, David earned more than 71.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,064 out of 14,244 | 72nd |
Division Manufacturing | 1,498 out of 5,759 | 74th |
Major group Chemicals And Allied Products | 531 out of 2,122 | 75th |
Industry group Drugs | 444 out of 1,811 | 76th |
Industry Pharmaceutical Preparations | 342 out of 1,385 | 75th |
Source: SEC filing on April 26, 2019.
David's colleagues
We found three more compensation records of executives who worked with Nathaniel E. David at Unity Biotechnology in 2018.